Inogen, Inc.
NASDAQ:INGN
7.13 (USD) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 335.705 | 315.66 | 377.241 | 358.003 | 308.487 | 361.943 | 358.111 | 249.438 | 202.829 | 159.005 | 112.537 | 75.443 | 48.576 | 30.634 |
| Cost of Revenue
| 180.964 | 188.961 | 223.708 | 181.52 | 170.307 | 190.082 | 179.531 | 128.201 | 105.519 | 82.747 | 57.02 | 36.452 | 24.627 | 15.93 |
| Gross Profit
| 154.741 | 126.699 | 153.533 | 176.483 | 138.18 | 171.861 | 178.58 | 121.237 | 97.31 | 76.258 | 55.517 | 38.991 | 23.949 | 14.704 |
| Gross Profit Ratio
| 0.461 | 0.401 | 0.407 | 0.493 | 0.448 | 0.475 | 0.499 | 0.486 | 0.48 | 0.48 | 0.493 | 0.517 | 0.493 | 0.48 |
| Reseach & Development Expenses
| 21.61 | 20.84 | 21.943 | 16.576 | 14.08 | 9.401 | 7.029 | 5.313 | 5.113 | 4.18 | 2.977 | 2.398 | 2.262 | 1.789 |
| General & Administrative Expenses
| 72.578 | 75.26 | 43.905 | 37.852 | 38.605 | 37.121 | 38.018 | 37.576 | 31.793 | 25.658 | 17.942 | 13.754 | 8.289 | 5.623 |
| Selling & Marketing Expenses
| 103.069 | 107.091 | 120.767 | 112.815 | 97.52 | 105.55 | 95.641 | 50.758 | 37.54 | 31.369 | 24.087 | 18.375 | 12.569 | 9.014 |
| SG&A
| 175.647 | 182.351 | 164.672 | 150.667 | 136.125 | 142.671 | 133.659 | 88.334 | 69.333 | 57.027 | 42.029 | 32.129 | 20.858 | 14.637 |
| Other Expenses
| 0 | 32.894 | -0.862 | -0.71 | 5.836 | -0.229 | -0.696 | 1.301 | -0.329 | -0.404 | -0.088 | 0.196 | 0.01 | 0 |
| Operating Expenses
| 197.257 | 236.085 | 186.615 | 167.243 | 150.205 | 152.072 | 140.688 | 93.647 | 74.446 | 61.207 | 45.006 | 34.527 | 23.12 | 16.426 |
| Operating Income
| -42.516 | -109.386 | 19.079 | -12.388 | -12.025 | 5.955 | 37.892 | 27.59 | 22.864 | 15.051 | 10.511 | 4.464 | 0.829 | -1.722 |
| Operating Income Ratio
| -0.127 | -0.347 | 0.051 | -0.035 | -0.039 | 0.016 | 0.106 | 0.111 | 0.113 | 0.095 | 0.093 | 0.059 | 0.017 | -0.056 |
| Total Other Income Expenses Net
| 6.04 | 7.042 | 1.975 | -0.581 | 6.745 | 4.483 | 2.563 | 2.066 | -0.139 | -0.324 | -0.459 | -0.616 | -0.247 | -0.267 |
| Income Before Tax
| -36.476 | -102.344 | -83.268 | 8.659 | -5.28 | 24.272 | 40.455 | 29.656 | 22.725 | 14.727 | 10.052 | 3.848 | 0.582 | -1.989 |
| Income Before Tax Ratio
| -0.109 | -0.324 | -0.221 | 0.024 | -0.017 | 0.067 | 0.113 | 0.119 | 0.112 | 0.093 | 0.089 | 0.051 | 0.012 | -0.065 |
| Income Tax Expense
| -0.588 | 0.105 | 0.504 | 14.992 | 0.549 | 3.322 | -11.39 | 8.654 | 2.206 | 3.142 | 3.226 | -21.587 | 0.018 | 0.013 |
| Net Income
| -35.888 | -102.449 | -83.772 | -6.333 | -5.829 | 20.95 | 51.845 | 21.002 | 20.519 | 11.585 | 6.826 | 25.435 | 0.564 | -2.002 |
| Net Income Ratio
| -0.107 | -0.325 | -0.222 | -0.018 | -0.019 | 0.058 | 0.145 | 0.084 | 0.101 | 0.073 | 0.061 | 0.337 | 0.012 | -0.065 |
| EPS
| -1.52 | -4.42 | -3.67 | -0.28 | -0.27 | 0.96 | 2.3 | 1.02 | 1.02 | 0.6 | 0.33 | 1.01 | -0.36 | -0.14 |
| EPS Diluted
| -1.52 | -4.42 | -3.67 | -0.28 | -0.27 | 0.94 | 2.3 | 0.96 | 0.97 | 0.56 | 0.3 | 1.01 | -0.36 | -0.12 |
| EBITDA
| -21.512 | -58.34 | -24.954 | 30.868 | 6.556 | 33.623 | 49.187 | 39.892 | 36.422 | 28.761 | 22.591 | 13.008 | 6.059 | 1.47 |
| EBITDA Ratio
| -0.064 | -0.185 | -0.066 | 0.086 | 0.021 | 0.093 | 0.137 | 0.16 | 0.18 | 0.181 | 0.201 | 0.172 | 0.125 | 0.048 |